Indo Amines Ltd
Incorporated in 1992, Indo Amines Limited is a global manufacturer and supplier of Fine & Specialty chemicals.[1]
- Market Cap ₹ 849 Cr.
- Current Price ₹ 117
- High / Low ₹ 176 / 95.0
- Stock P/E 12.1
- Book Value ₹ 49.6
- Dividend Yield 0.42 %
- ROCE 18.3 %
- ROE 19.0 %
- Face Value ₹ 5.00
Pros
- Company has delivered good profit growth of 34.0% CAGR over last 5 years
Cons
- Promoter holding has decreased over last 3 years: -9.93%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of BSE Allcap BSE Commodities
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 221 | 234 | 253 | 285 | 355 | 528 | 479 | 541 | 786 | 945 | 943 | 1,079 | 1,109 | |
| 202 | 212 | 222 | 249 | 314 | 473 | 437 | 479 | 734 | 858 | 863 | 977 | 996 | |
| Operating Profit | 18 | 22 | 30 | 36 | 41 | 55 | 42 | 61 | 52 | 87 | 80 | 101 | 113 |
| OPM % | 8% | 10% | 12% | 13% | 12% | 10% | 9% | 11% | 7% | 9% | 8% | 9% | 10% |
| 1 | 1 | 1 | 3 | 4 | 7 | 7 | 8 | 10 | 4 | 16 | 15 | 23 | |
| Interest | 4 | 5 | 4 | 4 | 8 | 10 | 11 | 9 | 14 | 17 | 22 | 22 | 24 |
| Depreciation | 6 | 10 | 12 | 12 | 12 | 15 | 20 | 11 | 14 | 17 | 15 | 17 | 19 |
| Profit before tax | 9 | 8 | 15 | 23 | 25 | 38 | 18 | 49 | 35 | 57 | 58 | 77 | 93 |
| Tax % | 36% | 35% | 38% | 29% | 36% | 34% | 30% | 23% | 33% | 28% | 26% | 27% | |
| 6 | 5 | 9 | 16 | 16 | 25 | 13 | 37 | 23 | 41 | 43 | 56 | 70 | |
| EPS in Rs | 0.93 | 0.80 | 1.38 | 2.46 | 2.40 | 3.78 | 1.92 | 5.31 | 3.23 | 5.72 | 6.05 | 7.61 | 9.65 |
| Dividend Payout % | 27% | 31% | 36% | 21% | 21% | 13% | 26% | 10% | 15% | 9% | 8% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 18% |
| 3 Years: | 11% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 34% |
| 3 Years: | 34% |
| TTM: | 35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | 7% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31 | 33 | 33 | 33 | 33 | 33 | 33 | 35 | 35 | 35 | 36 | 36 | 36 |
| Reserves | 10 | 12 | 17 | 36 | 48 | 92 | 102 | 127 | 152 | 190 | 228 | 281 | 324 |
| 54 | 51 | 50 | 62 | 91 | 131 | 143 | 159 | 207 | 232 | 217 | 284 | 307 | |
| 62 | 60 | 67 | 81 | 75 | 90 | 83 | 131 | 160 | 140 | 153 | 177 | 176 | |
| Total Liabilities | 156 | 155 | 167 | 213 | 246 | 346 | 362 | 453 | 554 | 597 | 635 | 779 | 843 |
| 34 | 53 | 51 | 64 | 70 | 116 | 117 | 125 | 182 | 198 | 209 | 265 | 268 | |
| CWIP | 12 | 1 | 0 | 2 | 5 | 8 | 24 | 54 | 22 | 20 | 23 | 35 | 65 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 3 |
| 110 | 102 | 115 | 147 | 171 | 222 | 221 | 274 | 350 | 379 | 401 | 476 | 507 | |
| Total Assets | 156 | 155 | 167 | 213 | 246 | 346 | 362 | 453 | 554 | 597 | 635 | 779 | 843 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 23 | 19 | 15 | 8 | 27 | 39 | 56 | 15 | 20 | 70 | 35 | |
| -21 | -14 | -10 | -23 | -21 | -43 | -36 | -50 | -39 | -30 | -27 | -82 | |
| 2 | -9 | -9 | 7 | 16 | 17 | -3 | -1 | 32 | 4 | -41 | 42 | |
| Net Cash Flow | 0 | 1 | 0 | -1 | 3 | 2 | 0 | 5 | 9 | -5 | 2 | -5 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 83 | 62 | 66 | 78 | 76 | 78 | 73 | 89 | 78 | 72 | 84 | 86 |
| Inventory Days | 55 | 59 | 60 | 66 | 84 | 68 | 98 | 96 | 86 | 78 | 65 | 73 |
| Days Payable | 87 | 68 | 66 | 80 | 101 | 80 | 80 | 113 | 88 | 60 | 68 | 67 |
| Cash Conversion Cycle | 51 | 52 | 60 | 64 | 59 | 66 | 91 | 71 | 76 | 91 | 82 | 93 |
| Working Capital Days | -10 | -12 | 6 | -38 | 9 | 5 | 10 | 9 | 1 | 17 | 27 | 28 |
| ROCE % | 15% | 14% | 19% | 23% | 22% | 22% | 11% | 19% | 14% | 17% | 17% | 18% |
Documents
Announcements
-
Board Meeting Intimation for Intimation Of Board Meeting For Consideration Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December, 2025
2d - Board meeting on 07 Feb 2026 to approve unaudited results for quarter and nine months ended 31 Dec 2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Jan - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2025.
- Closure of Trading Window 30 Dec 2025
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov 2025 - Newspaper publication of Unaudited Financial Results for the quarter ended 30th September, 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, November 12, 2025
12 Nov 2025 - Q2/H1 results (30 Sep 2025): Revenue Rs27,197.32L; PBT Rs2,787.24L; limited review.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Aug 2021TranscriptAI SummaryPPT
-
Jun 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
Business Overview:[1][2][3]
IAL is engaged in the chemical intermediates business with a product
basket of 70+ products. It is a manufacturer, developer, and supplier of:
a) Fine Chemicals
b) Speciality Chemicals
c) Performance Chemicals
d) Perfumery Chemicals
e) Active Pharmaceutical Ingredients